Lunai Bioworks Inc. (LNAI) earnings date, market-implied expected move, and options open interest by expiry

earnings room

2.32−0.64%

Next report

fiscal Q1 2027

Oct 19

timing tbd · estimated date

days out

Intraday

+1.54% since 4 AM

High 2.32 at 1:15 pm ET, low 2.26 at 11:00 am ET.

Revenue flow

Q3 FY2026 as filed · change vs Q2 FY2026

LNAI lost 12278.65% of Q3 FY2026 revenue.

Revenue$20,942—

Gross profit$20,942100.00%—

Operating income−$1M−7054.05%+18.98%

Pre-tax income−$3M−42.90%

Net income−$3M−12278.65%−42.90%

What left, as a share of revenue

Cost of revenue$0—

Operating expenses$1M−20.58%

What else left

Other income−$1M−4865.24%

Standardized lines from LNAI’s own filing for the quarter ended Mar 31 '26. Bars are each line as a share of revenue.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

1 expiries · as of the Sep 19 close

Contracts already committed, not just traded today. Puts against calls, sized by expiry.

Oct 16

27d

697

putscalls

Earnings history

implied in pale · realized in full ink

The record starts accreting with the next priced report.

2-quarter memory

Event sensitivity

release-day history · not a forecast

NFPjobs report1.4×up 4 of 9±10.4% vs ±7.5% · 9
FOMCrate decision1.1×up 7 of 24±8.3% vs ±7.5% · 24
PPIproducer prices1.1×up 1 of 9±8.2% vs ±7.5% · 9
CPROFcorporate profits1.0×up 6 of 11±7.7% vs ±7.5% · 11
PCEpersonal income & outlays0.9×up 5 of 18±6.6% vs ±7.5% · 18
GDPgross domestic product0.8×up 7 of 18±6.0% vs ±7.5% · 18
CPIconsumer prices0.7×up 3 of 9±5.0% vs ±7.5% · 9

Past release days against LNAI’s ordinary ±7.5% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track LNAI

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.